Particle.news

Download on the App Store

UnitedHealth Faces Leadership Shakeup and DOJ Probes Amid $280 Billion Stock Wipeout

Stephen Hemsley returns as CEO to steer UnitedHealth through financial turmoil, criminal investigations, and insider trading allegations following Andrew Witty's resignation.

Overview

  • Stephen Hemsley, former CEO of UnitedHealth, has returned to lead the company after Andrew Witty's abrupt resignation, citing personal reasons.
  • UnitedHealth's stock has plummeted over 50% in the past month, erasing $280 billion in market value after disappointing earnings and ongoing legal challenges.
  • The Department of Justice is conducting criminal and antitrust investigations into UnitedHealth's Medicare Advantage practices, including allegations of fraudulent coding to inflate payments.
  • A class-action lawsuit accuses Hemsley, Witty, and former executive Brian Thompson of insider trading, claiming they sold shares before disclosing a DOJ antitrust probe.
  • UnitedHealth has withdrawn its 2025 financial outlook, citing higher-than-expected Medicare Advantage costs and operational forecasting challenges.